Table 3.
Predictors of Chronic Kidney Disease Documentation in multivariate analysis
| CKD Diagnosis Documentation Prediction Variables | aOR of CKD documentation (95%CI) | P value |
|---|---|---|
| Age at baseline (by 1 year of increase) | 0.98 (0.98-0.99) | < .0001 |
| eGFR** 40-49 vs 50-59 | 2.55 (2.17-3.00) | < .0001 |
| eGFR 40-39 vs 50-59 | 7.39 (6.19-8.82) | < .0001 |
| eGFR 20-29 vs 50-59 | 18.37 (14.59-23.13) | < .0001 |
| eGFR 10-19 vs 50-59 | 35.33 (25.14-49.65) | < .0001 |
| Coronary artery disease | 1.05 (0.87-1.25) | 0.5882 |
| Cerebrovascular disease | 1.22 (0.80-1.85) | 0.3477 |
| Peripheral artery disease | 1.51 (1.19-1.93) | 0.0008 |
| Chronic heart failure | 1.44 (1.18-1.78) | 0.0004 |
| Statin use | 1.22 (1.03-1.46) | 0.0194 |
| ACEI use | 0.97 (0.82-1.15) | 0.7673 |
| NSAID use | 0.81 (0.65-1.01) | 0.0705 |
*Significant interactions in multivariate model were found between type 2 diabetes and gender with respect to CKD documentation (p value for interaction = 0.0053), as well as between type 2 diabetes and hypertension (p value for interaction = 0.0065) with respect to CKD documentation.
**eGFR in ml/min/1.73 m2